- Scancell to produce TCB antibodies
- Second Price Monitoring Extn
- Price Monitoring Extension
- Phase 2 SCOPE trial of SCIB1 vaccine expanded
- First patient dosed in Modi-1 Phase 1 trial
- Change of Registered Holder of Shares
- Modi-1 Phase 1/2 trial open for recruitment
- Update on COVIDITY clinical trial
- Scancell progresses its new anti-glycan mAb
- Director Dealing
More ▼
Key statistics
As of last trade, Scancell Holdings PLC (SCLP:LSE) traded at 13.20, 25.71% above the 52 week low of 10.50 set on Apr 08, 2022.
52-week range
Markit short selling activity
Open | 12.88 |
---|---|
High | 14.50 |
Low | 14.50 |
Bid | 13.00 |
Offer | 13.25 |
Previous close | 12.88 |
Average volume | 429.05k |
---|---|
Shares outstanding | 815.22m |
Free float | 714.66m |
P/E (TTM) | -- |
Market cap | 104.96m GBP |
EPS (TTM) | -0.0105 GBP |
Data delayed at least 20 minutes, as of Jul 01 2022 10:28 BST.
More ▼